Status:
RECRUITING
A Study of Chios Mastic Water in Dyspepsia
Lead Sponsor:
Harokopio University
Conditions:
Dyspepsia
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
Chios mastic is a natural product with strong antimicrobial, anti-inflammatory and antioxidant properties, and well-established benefits for dyspeptic disorders. The aim of the present study is to inv...
Detailed Description
The term "dyspepsia" encompasses a wide range of upper gastrointestinal symptoms, including early satiety, abdominal pain, flatulence, bloating, postprandial fullness or discomfort, nausea, vomiting, ...
Eligibility Criteria
Inclusion
- Age 30-60 years old.
- Body mass index of 20-35 kg/m2.
- Presence of dyspepsia.
Exclusion
- Presence of chronic diseases (e.g. diabetes mellitus, cancer, cardiovascular, hepatic, renal, respiratory, chronic inflammatory and psychiatric diseases).
- Presence of other chronic gastrointestinal diseases (e.g. gastroesophageal reflux, inflammatory bowel disease and celiac disease).
- Use of immunosuppressants, anti-inflammatories, antibiotics and corticosteroids.
- Use of dietary supplements or other products with Chios mastic.
- Excessive alcohol consumption (\>210 g and \>140 g of ethanol per week for men and women, respectively).
- Currently on a weight-loss diet or recent (within 6 months) significant change in lifestyle habits.
- Pregnancy or breast feeding (for women)
Key Trial Info
Start Date :
July 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06909890
Start Date
July 10 2025
End Date
December 1 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University of Athens
Kallithea, Attica, Greece, 17676